$7.21
0.131.84%
Last update: 12:49 PM
15 minutes delayed
Comments
Loading...
Kala Bio
KALANASDAQ
Kala Bio (NASDAQ:KALA) Stock, Insider Trading Activity
Kala Bio: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Kala Bio Inc Insiders Doing?
At Kala Bio Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 34.63K shares worth $164.50K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 3, 2024, Darius Kharabi, the company's CHIEF BUSINESS OFFICER sold 231 shares for $6.09 each.
- On June 3, 2024, Mary Reumuth, the company's CHIEF FINANCIAL OFFICER sold 1.79K shares for $6.09 each.
- On June 3, 2024, Romulus Brazzell, the company's SEE REMARKS sold 2K shares for $6.09 each.
Ownership Statistics for Kala Bio Inc
Institutional Shares Held
109.226K
Institutional Percentage Held
2.45%
| Jun 27, 2024 | Todd Bazemore | SEE REMARKS | -4.65K | $4.75 | -$22.10K | SELL | -5.31% | 83.04K | Jun 26 | View |
| Jun 27, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | -5.16K | $4.75 | -$24.50K | SELL | -7.95% | 59.73K | Jun 26 | View |
| Jun 27, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -4.16K | $4.75 | -$19.77K | SELL | -6.47% | 60.19K | Jun 26 | View |
| Jun 27, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -15.17K | $4.75 | -$72.05K | SELL | -5.44% | 263.75K | Jun 26 | View |
| Jun 27, 2024 | Romulus Brazzell | SEE REMARKS | -5.49K | $4.75 | -$26.07K | SELL | -6.13% | 83.98K | Jun 26 | View |
| Jun 03, 2024 | Todd Bazemore | SEE REMARKS | -2.09K | $6.09 | -$12.75K | SELL | -2.33% | 87.69K | May 31 | View |
| Jun 03, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | -231.00 | $6.09 | -$1.41K | SELL | -0.35% | 64.89K | May 31 | View |
| Jun 03, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -1.79K | $6.09 | -$10.88K | SELL | -2.70% | 64.35K | May 31 | View |
| Jun 03, 2024 | Romulus Brazzell | SEE REMARKS | -2.00K | $6.09 | -$12.19K | SELL | -2.19% | 89.47K | May 31 | View |
| Jun 03, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.39K | $6.09 | -$45.02K | SELL | -2.58% | 278.92K | May 31 | View |
| Jan 05, 2024 | Eric Trachtenberg | SEE REMARKS | 3.37K | $6.74 | -$8.27K | GRANT | 5.21% | 68.07K | Jan 04 | View |
| Jan 05, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | 3.21K | $6.73 | -$9.32K | GRANT | 5.19% | 65.12K | Jan 04 | View |
| Jan 05, 2024 | Romulus Brazzell | SEE REMARKS | 4.88K | $6.74 | -$10.90K | GRANT | 5.64% | 91.47K | Jan 04 | View |
| Jan 05, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | 9.76K | $6.73 | -$30.55K | GRANT | 3.53% | 286.31K | Jan 04 | View |
| Jan 05, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | 3.37K | $6.74 | -$8.27K | GRANT | 5.37% | 66.14K | Jan 04 | View |
| Jan 05, 2024 | Todd Bazemore | SEE REMARKS | 5.09K | $6.74 | -$9.47K | GRANT | ∞ | 1.00 | Jan 04 | View |
| Jan 06, 2023 | Eric Trachtenberg | SEE REMARKS | 9.46K | $28.55 | -$1.71K | GRANT | 466.26% | 11.49K | Jan 04 | View |
| Jan 06, 2023 | Mary Reumuth | CHIEF FINANCIAL OFFICER | 9.46K | $28.54 | -$1.71K | GRANT | 391.44% | 11.88K | Jan 04 | View |
| Jan 06, 2023 | Romulus Brazzell | SEE REMARKS | 12.73K | $28.53 | -$2.08K | GRANT | 219.09% | 18.54K | Jan 04 | View |
| Jan 06, 2023 | Todd Bazemore | SEE REMARKS | 12.74K | $28.54 | -$1.77K | GRANT | 607.15% | 14.84K | Jan 04 | View |
| Jan 06, 2023 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | 41.50K | $28.54 | -$5.65K | GRANT | 929.70% | 45.97K | Jan 04 | View |
| Oct 28, 2022 | Eric Trachtenberg | SEE REMARKS | -194.00 | $6.52 | -$1.26K | SELL | -8.72% | 2.03K | Oct 26 | View |
| Oct 28, 2022 | Todd Bazemore | SEE REMARKS | -214.00 | $6.51 | -$1.39K | SELL | -9.26% | 2.10K | Oct 26 | View |
| Oct 28, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -194.00 | $6.51 | -$1.26K | SELL | -7.43% | 2.42K | Oct 26 | View |
| Oct 28, 2022 | Romulus Brazzell | SEE REMARKS | -261.00 | $6.51 | -$1.70K | SELL | -4.30% | 5.81K | Oct 26 | View |
| Oct 28, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -561.00 | $6.52 | -$3.66K | SELL | -11.16% | 4.46K | Oct 26 | View |
| Jun 29, 2022 | Eric Trachtenberg | SEE REMARKS | -2.61K | $0.37 | -$966.81 | SELL | -2.30% | 111.20K | Jun 27 | View |
| Jun 29, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.61K | $0.37 | -$966.81 | SELL | -1.96% | 130.59K | Jun 27 | View |
| Jun 29, 2022 | Romulus Brazzell | SEE REMARKS | -3.14K | $0.37 | -$1.16K | SELL | -1.09% | 285.20K | Jun 27 | View |
| Jun 29, 2022 | Todd Bazemore | SEE REMARKS | -3.09K | $0.37 | -$1.14K | SELL | -2.61% | 115.54K | Jun 27 | View |
| Jun 29, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.97K | $0.37 | -$2.95K | SELL | -3.08% | 251.18K | Jun 27 | View |
| May 26, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | -1.01M | $0.36 | -$365.67K | SELL | -12.50% | 7.04M | May 26 | View |
| May 25, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | -2.83M | $0.53 | -$1.49M | SELL | -26.02% | 8.05M | May 23 - May 25 | View |
| Jan 05, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.85K | $1.30 | -$3.71K | SELL | -2.09% | 133.21K | Jan 04 | View |
| Jan 05, 2022 | Romulus Brazzell | SEE REMARKS | -3.50K | $1.30 | -$4.56K | SELL | -1.20% | 288.35K | Jan 04 | View |
| Jan 05, 2022 | Todd Bazemore | SEE REMARKS | -3.45K | $1.30 | -$4.49K | SELL | -2.83% | 118.63K | Jan 04 | View |
| Jan 05, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -9.52K | $1.30 | -$12.37K | SELL | -3.54% | 259.16K | Jan 04 | View |
| Jan 05, 2022 | Eric Trachtenberg | SEE REMARKS | -2.85K | $1.30 | -$3.71K | SELL | -2.44% | 113.82K | Jan 04 | View |
| Oct 28, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -30.50K | $1.81 | -$55.32K | SELL | -12.98% | 204.51K | Oct 26 - Oct 27 | View |
| Oct 28, 2021 | Eric Trachtenberg | SEE REMARKS | -9.45K | $1.80 | -$17.01K | SELL | -7.49% | 116.67K | Oct 26 | View |
| Oct 28, 2021 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -9.45K | $1.80 | -$17.01K | SELL | -6.49% | 136.06K | Oct 26 | View |
| Oct 28, 2021 | Todd Bazemore | CHIEF OPERATING OFFICER | -12.54K | $1.80 | -$22.58K | SELL | -9.32% | 122.09K | Oct 26 | View |
| Oct 28, 2021 | Romulus Brazzell | CHIEF MEDICAL OFFICER | -12.76K | $1.80 | -$22.96K | SELL | -4.19% | 291.85K | Oct 26 | View |
| Oct 28, 2021 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -27.60K | $1.80 | -$49.68K | SELL | -9.32% | 268.68K | Oct 26 | View |
| Jun 30, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -5.55K | $5.56 | -$30.85K | SELL | -2.31% | 235.01K | Jun 29 | View |
| Jun 29, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -2.45K | $5.77 | -$14.15K | SELL | -1.01% | 240.56K | Jun 28 | View |
| Jun 29, 2021 | Romulus Brazzell | CHIEF MEDICAL OFFICER | -3.03K | $5.77 | -$17.51K | SELL | -1.00% | 300.96K | Jun 28 | View |
| Jun 29, 2021 | Eric Trachtenberg | SEE REMARKS | -2.45K | $5.77 | -$14.15K | SELL | -1.91% | 126.11K | Jun 28 | View |
| Jun 29, 2021 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.45K | $5.77 | -$14.15K | SELL | -1.66% | 145.51K | Jun 28 | View |
| Jun 29, 2021 | Todd Bazemore | CHIEF OPERATING OFFICER | -2.91K | $5.77 | -$16.80K | SELL | -98.58% | 42.00 | Jun 28 | View |
| Jun 29, 2021 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.59K | $5.77 | -$43.77K | SELL | -2.50% | 296.27K | Jun 28 | View |
| Oct 28, 2020 | Todd Bazemore | — | 81.04K | $7.88 | $330.78 | GRANT OR AWARD | ∞ | 42.00 | Jun 05 - Oct 26 | View |
| Mar 17, 2020 | Todd Bazemore | — | 10.00K | $5.75 | $57.50K | PURCHASE | ∞ | 10.00K | Mar 16 | View |
| Mar 16, 2020 | Gregory Grunberg | — | 2.53M | $7.89 | $20.00M | PURCHASE | 88.11% | 5.41M | Mar 13 | View |
| Mar 13, 2020 | Rajeev Shah individually | — | 6.34M | $7.89 | $50.00M | PURCHASE | 139.66% | 10.87M | Mar 13 | View |
| Mar 13, 2020 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter Kolchinsky | — | 6.34M | $7.89 | $50.00M | PURCHASE | 139.66% | 10.87M | Mar 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.